¿Cómo realizamos el cribado de infección tuberculosa latente en pacientes candidatos a terapias biológicas en España? Una encuesta multidisciplinar.

Citation data:

Archivos de bronconeumologia, ISSN: 1579-2129, Vol: 54, Issue: 10, Page: 510-517

Publication Year:
2018
Captures 10
Readers 10
Social Media 2
Tweets 2
PMID:
29941293
DOI:
10.1016/j.arbres.2018.04.004
Author(s):
Quirós, Sarai; de la Rosa, David; Uranga, Ane; Madero, Rosario; Amaro, Rosanel; Bruguera, Nuria; García, Julia A; Gómez, C; Iturbe, David; Lera, Rubén; Luque, Lydia; Martínez, Abel J; Mínguez, Patricia; Navarro, Annie; Sánchez, Gema; Suárez-Cuartín, Guillermo Show More Hide
Publisher(s):
Elsevier BV
Tags:
Medicine
Most Recent Tweet View All Tweets
article description
Treatment with biological therapies increases the incidence of tuberculous disease. The introduction of systematic screening for latent tuberculosis infection in patients who are to receive these therapies has reduced this risk. In 2016, the consensus document on the prevention and treatment of tuberculosis in patients who are candidates for biological treatment was published in Spain. The main objective of this study was to evaluate adherence to these guidelines.